CCL2 and neoplasm: SHP has also been shown to play a partial tumor-suppressive role, because FXR-mediated transcriptional activation of SHP inhibits the expression of cyclin D1 and C-C motif chemokine ligand 2 (CCL2), reducing the proliferation and invasion of tumor cells (Yu et al., 2020a).